RaQualia Pharma Inc
TSE:4579
RaQualia Pharma Inc
TSE:4579
Price:
593 JPY
-0.17%
Market Closed
Updated:
May 20, 2024
RaQualia Pharma Inc
Operating Expenses
|
RaQualia Pharma Inc
Operating Expenses Peer Comparison
Comparables:
4502
4568
4578
4519
4503
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
RaQualia Pharma Inc
TSE:4579
|
Operating Expenses
-¥2B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
2%
|
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Operating Expenses
-¥2.6T
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-9%
|
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Operating Expenses
-¥974.8B
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-7%
|
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Operating Expenses
-¥1.2T
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-4%
|
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Operating Expenses
-¥259.9B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-5%
|
|
|
Astellas Pharma Inc
TSE:4503
|
Operating Expenses
-¥1.3T
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-8%
|
See Also
What is RaQualia Pharma Inc's Operating Expenses?
Operating Expenses
-2B
JPY
-2B
JPY
Based on the financial report for Dec 31, 2023, RaQualia Pharma Inc's Operating Expenses amounts to -2B JPY.
What is RaQualia Pharma Inc's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
2%
2%
Over the last year, the Operating Expenses growth was -10%. The average annual Operating Expenses growth rates for RaQualia Pharma Inc have been -11% over the past three years , -3% over the past five years , and 2% over the past ten years .
You don't have any saved screeners yet
